259816-44-9

Basic information

• Product Name: Ethanamine, 2-(4-pyridinyloxy)- (9CI)
• Synonyms: Ethanamine, 2-(4-pyridinyloxy)- (9CI);2-(pyridin-4-yloxy)ethanaMine hydrochloride;2-(Pyridin-4-yloxy)ethanamine;2-(Pyridin-4-yloxy)-ethylamine;2-(4-Pyridinyloxy)ethanamine;2-(4-PYRIDINYLOXY)-ETHANAMINE hydrochloride
• CAS NO: 259816-44-9
• Molecular Formula: C₇H₁₀N₂O
• Molecular Weight: 138.1671
• Product Categories: PYRIDINE
• Mol File: 259816-44-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 258.8±20.0 °C(Predicted)
• Appearance: /
• Density: 1.089±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 7.76±0.10(Predicted)
• CAS DataBase Reference: Ethanamine, 2-(4-pyridinyloxy)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanamine, 2-(4-pyridinyloxy)- (9CI)(259816-44-9)
• EPA Substance Registry System: Ethanamine, 2-(4-pyridinyloxy)- (9CI)(259816-44-9)

Safety Data

• Hazardous Substances Data: 259816-44-9(Hazardous Substances Data)

Usage

General Description

Ethanamine, 2-(4-pyridinyloxy)- (9CI) is a chemical compound with the molecular formula C8H11NO2. Its key aspect is the presence of pyridine, a basic heterocyclic organic compound that is structurally related to benzene. As a derivative of ethanamine, it contains an amine functional group, comprising a nitrogen atom attached to hydrogen atoms and/or alkyl groups. The precise properties and potential applications of this compound depend on how it interacts and behaves with other chemicals in various conditions. However, detailed specifics regarding its usage, toxicity, handling precautions, and environmental impacts are not readily available and would require further research and analysis.

Upstream product

• 626-64-2 pyridin-4-ol 
• 155966-39-5 4-(2-phthalimidoethyloxy)pyridine 
• 7379-35-3 4-chlorpyridine hydrochloride 
• 141-43-5 ethanolamine 

Relevant articles and documents

Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents

A series of benzamide scaffolds were designed and synthesized by the thiazinone ring opening of PBTZ169, and N-benzyl 3,5-dinitrobenzamides were finally identified as anti-TB agents in this work. 3,5-Dinitrobenzamides D5, 6, 7, and 12 exhibit excellent in vitro activity against the drug susceptive Mycobacterium tuberculosis H37Rv strain (MIC: 0.0625 μg/mL) and two clinically isolated multidrug-resistant strains (MIC 0.016-0.125 μg/mL). Compound D6 displays acceptable safety and better pharmacokinetic profiles than PBTZ169, suggesting its promising potential to be a lead compound for future antitubercular drug discovery.

New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7β-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2- ethoxyiminoacetamido] cephalosporins beari

Among the prepared C-3′ substituted-pyridinium cephalosporins, a series of 7β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3′ showed highly potent antibacterial activity agai